Global Muscle Relaxers Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Muscle Relaxers market size will reach US$ 5406 million by 2031.
Muscle relaxers are a group of drugs that have a sedative effect and may be prescribed for back, neck, and other musculoskeletal pain.
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth. For instance, 1 in 6 people worldwide will be 60 or older by 2030. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Between 2020 and 2050, the number of people 80 or older is projected to triple, reaching 426 million.
LPI (LP Information)' newest research report, the “Muscle Relaxers Industry Forecast” looks at past sales and reviews total world Muscle Relaxers sales in 2024, providing a comprehensive analysis by region and market sector of projected Muscle Relaxers sales for 2025 through 2031. With Muscle Relaxers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Muscle Relaxers industry.
This Insight Report provides a comprehensive analysis of the global Muscle Relaxers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Muscle Relaxers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Muscle Relaxers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Muscle Relaxers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Muscle Relaxers.
This report presents a comprehensive overview, market shares, and growth opportunities of Muscle Relaxers market by product type, application, key players and key regions and countries.
Segmentation by Type:
Methocarbamol
Cyclobenzaprine
Tizanidine
Baclofen
Others
Segmentation by Application:
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Allergan
Ipsen Group
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Par Sterile Products
Acorda Therapeutics
SteriMax Inc
Emcure Pharmaceuticals
Upsher-Smith Laboratories
Orient Pharma
Daewoong Pharmaceutical
Please note: The report will take approximately 2 business days to prepare and deliver.
Muscle relaxers are a group of drugs that have a sedative effect and may be prescribed for back, neck, and other musculoskeletal pain.
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth. For instance, 1 in 6 people worldwide will be 60 or older by 2030. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Between 2020 and 2050, the number of people 80 or older is projected to triple, reaching 426 million.
LPI (LP Information)' newest research report, the “Muscle Relaxers Industry Forecast” looks at past sales and reviews total world Muscle Relaxers sales in 2024, providing a comprehensive analysis by region and market sector of projected Muscle Relaxers sales for 2025 through 2031. With Muscle Relaxers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Muscle Relaxers industry.
This Insight Report provides a comprehensive analysis of the global Muscle Relaxers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Muscle Relaxers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Muscle Relaxers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Muscle Relaxers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Muscle Relaxers.
This report presents a comprehensive overview, market shares, and growth opportunities of Muscle Relaxers market by product type, application, key players and key regions and countries.
Segmentation by Type:
Methocarbamol
Cyclobenzaprine
Tizanidine
Baclofen
Others
Segmentation by Application:
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Allergan
Ipsen Group
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Par Sterile Products
Acorda Therapeutics
SteriMax Inc
Emcure Pharmaceuticals
Upsher-Smith Laboratories
Orient Pharma
Daewoong Pharmaceutical
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
129 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
